Kazuya Kamada
Overview
Explore the profile of Kazuya Kamada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamada K, Shoji I, Deng L, Aoki C, Ratnoglik S, Wakita T, et al.
Microbes Infect
. 2011 Sep;
14(1):69-78.
PMID: 21917232
The lack of a culture system that efficiently produces progeny virus has hampered hepatitis C virus (HCV) research. Recently, the discovery of a novel HCV isolate JFH1 and its chimeric...
2.
Kamada K, Yamashita T, Hatcho K, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Dec;
11(2):164-71.
PMID: 19056509
We have recently generated a monkey cell-tropic virus termed NL-DT5R from an HIV-1 NL4-3 clone and demonstrated that both cyclophilin A (CypA)-binding loop in Gag-capsid (CA) and Vif are responsible...
3.
Hatcho K, Kamada K, Yamashita T, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Jul;
10(10-11):1218-22.
PMID: 18617010
To obtain monkey-tropic viruses that are more closely related to HIV-1 than the original NL-DT5/NL-DT5R clones, we constructed six vif-chimeric and two site-specific vif-mutant viruses, and examined their growth ability....
4.
Yamashita T, Kamada K, Hatcho K, Adachi A, Nomaguchi M
Microbes Infect
. 2008 Jul;
10(10-11):1142-9.
PMID: 18603011
To define a region(s) in human immunodeficiency virus type 1 (HIV-1) Vif that involves binding to its target APOBEC3G (A3G), we have generated a series of site-specific proviral vif mutants....
5.
Nomaguchi M, Doi N, Kamada K, Adachi A
Rev Med Virol
. 2008 Apr;
18(4):261-75.
PMID: 18386279
Monkey infection models are absolutely necessary for studies of human immunodeficiency virus type 1 (HIV-1) pathogenesis and of developing drugs/vaccines against HIV-1. In addition, currently unknown roles of its accessory...
6.
Adachi A, Kamada K, Hatcho K, Yamashita T, Uchiyama T, Nomaguchi M
Tanpakushitsu Kakusan Koso
. 2007 Sep;
52(10 Suppl):1261-7.
PMID: 17824250
No abstract available.
7.
Igarashi T, Iyengar R, Byrum R, Buckler-White A, Dewar R, Buckler C, et al.
J Virol
. 2007 Aug;
81(20):11549-52.
PMID: 17670817
A human immunodeficiency virus type 1 (HIV-1) derivative (HIV(NL-DT5R)) containing sequences encoding a 7-amino-acid segment of CA and the entire vif gene from simian immunodeficiency virus (SIV) was previously shown...
8.
Kamada K, Igarashi T, Martin M, Khamsri B, Hatcho K, Yamashita T, et al.
Proc Natl Acad Sci U S A
. 2006 Oct;
103(45):16959-64.
PMID: 17065315
The narrow host range of human immunodeficiency virus type 1 (HIV-1) is caused in part by innate cellular factors such as apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) and TRIM5alpha,...
9.
Khamsri B, Fujita M, Kamada K, Piroozmand A, Yamashita T, Uchiyama T, et al.
Int J Mol Med
. 2006 Sep;
18(4):679-83.
PMID: 16964423
We previously demonstrated that the expression in cells of human immunodeficiency virus type 1 (HIV-1) Vif is maintained at low level by proteasome-degradation. We examined the contribution of 16 lysines...
10.
Kamada K, Kuroishi A, Kamahora T, Kabat P, Yamaguchi S, Hino S
J Gen Virol
. 2006 Jul;
87(Pt 8):2227-2233.
PMID: 16847118
The existence of spliced mRNA in Chicken anemia virus (CAV) was investigated, as three proteins appeared to be derived from a single 2.0 kb mRNA species. Human Torque teno virus...